Related Experiment Video
Updated: Sep 4, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
Lin Luo1,2, Yingwei Zhen1, Dazhao Peng3
1Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 480082, China.
Abstract:
Non-coding RNAs (ncRNAs) account for the majority of the widespread transcripts of mammalian genomes. They rarely encode proteins and peptides, but their regulatory role is crucial in numerous physiological and pathological processes. The m6A (N6-methyladenosine) modification is one of the most common internal RNA modifications in eukaryotes and is associated with all aspects of RNA metabolism. Accumulating researches have indicated a close association between m6A modification and ncRNAs, and suggested m6A-modified ncRNAs played a crucial role in tumor progression. The correlation between m6A modification and ncRNAs offers a novel perspective for investigating the potential mechanisms of cancer pathological processes, which suggests that both m6A modification and ncRNAs are critical prognostic markers and therapeutic targets in numerous malignancies. In the present report, we summarized the interaction between m6A modification and ncRNA, emphasizing how their interaction regulates pathological processes in cancer.
Insights
Non-coding RNAs (ncRNAs) and N6-methyladenosine (m6A) modification are key regulators in cancer. Their interaction influences tumor progression, offering new insights into cancer mechanisms and potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Non-coding RNAs (ncRNAs) are abundant mammalian transcripts with critical regulatory roles.
- N6-methyladenosine (m6A) is a prevalent RNA modification influencing RNA metabolism.
- Both ncRNAs and m6A modification are increasingly linked to cancer development and progression.
Purpose of the Study:
- To summarize the intricate relationship between m6A modification and ncRNAs.
- To elucidate how this interaction impacts pathological processes in cancer.
- To highlight their significance as prognostic markers and therapeutic targets in malignancies.
Main Methods:
- Literature review and synthesis of existing research on m6A modification and ncRNAs in cancer.
- Analysis of studies demonstrating the functional interplay between m6A-modified ncRNAs and cancer pathways.
- Review of evidence supporting their roles in tumor progression and clinical relevance.
Main Results:
- m6A modification significantly affects ncRNA structure, stability, and function.
- m6A-modified ncRNAs play diverse roles in regulating gene expression, cell proliferation, and metastasis in cancer.
- The interplay between m6A and ncRNAs is a critical determinant of cancer pathology.
Conclusions:
- The m6A-ncRNA axis represents a novel and crucial mechanism in cancer.
- Targeting m6A modification or specific ncRNAs holds promise for cancer diagnostics and therapeutics.
- Further research into this interaction can uncover new avenues for cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Nuclear Export of mRNA
Epigenetic Regulation
Types of RNA
RNA Performs Diverse...
RNA Stability

